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Abstract High concentrations of ketoacid substrates inhibit 
most natural hydroxyacid dehydrogenases due to the formation 
of an abortive enzyme-NAD+-ketoacid complex. It was 
postulated that this substrate inhibition could be eliminated from 
lactate dehydrogenases if the rate of NAD + dissociation could be 
increased. An analysis of the crystal structure of mammalian 
IDHs  showed that the amide of the nicotinamide cofactor 
formed a water-bridged hydrogen bond to S163. The LDH of 
Plasmodium falciparum is not inhibited by its substrate and, 
uniquely, in this enzyme the serine is replaced by a leucine. In the 
S163L mutant of human LDH-M4 pyruvate inhibition is, indeed, 
abolished and the enzyme retains high activity. However, the 
major contribution to this effect comes from a weakening of the 
interaction of pyruvate with the enzyme-coenzyme complex. 
delbrueckii subsp, bulgaricus where removal of substrate inhi- 
bition occurs when histidine-205 is replaced by glutamine, 
thus losing an ionic contribution to cofactor binding via the 
pyrophosphate group [6]. 
In this paper we describe the modelling and preparation of 
two variants of hM4LDH, replacing the serine at position 163 
by alanine and leucine, and we compare the kinetic and bind- 
ing behaviours of these proteins with the wild type. The 
S163L mutant showed no detectable substrate inhibition, 
but the cause for this is not simply due to reduced NAD + 
binding. 
2. Materials and methods 
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1. Introduction 
A common feature of lactate dehydrogenases is their inhibi- 
lion by excess substrate when converting pyruvate to lactate. 
"i'he LDH from human muscle is a typical example, while it 
l~as a high value of kc,~t it is strongly inhibited by pyruvate [1]. 
"'his greatly reduces its efficiency as a catalyst for the stereo- 
,pecific reduction of pyruvate derivatives to produce drug 
,ynthons in the laboratory or industrial context. The cause 
~f this inhibition is known to be the formation of a covalent 
'~dduct between the oxidised forms of substrate and cofactor, 
.e. pyruvate and NAD ÷ [2]. A natural example lacking sub- 
,trate inhibition is afforded by the LDH from the malarial 
parasite, Plasmodium falciparum [3]. This protein is unique 
~n the family of lactate dehydrogenases in having a leucine 
:esidue at position 163 in place of serine. The hydroxyl group 
~f this serine hydrogen bonds to the nicotinamide amide of 
~/ADH, via a water molecule, in all other known LDH crystal 
,tructures [4]. Inspection of a model of p JLDH derived from 
he  gene sequence and known LDH structures uggests that 
he  loss of a good interaction between residue 163 and the 
l icotinamide ring might be, at least in part, responsible for 
he  loss of substrate inhibition by reducing the productive 
~inding of the oxidised cofactor, NAD + [5]. An engineered 
.'xample is known in the case of D-LDH from Lactobacillus 
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2.1. Molecular modelling 
In the absence of a human LDH crystal structure the coordinates of 
the pig structure were used for modelling as the sequence of amino 
acids differs in only 23 positions on the surface of the protein and 
remote from the active site. A single subunit of the ternary complex of 
pigM4-LDH with NADH and oxamate [7] was set up for calculation 
in the following manner. The first 19 residues of the N-terminus were 
deleted as these pack against a second subunit, the oxamate was 
converted to pyruvate, hydrogen atoms were added consistent with 
pH 7.0 and extra water molecules added to a depth of 5 ]k over the 
surface. Residue replacement of serine-163 generated the alanine and 
leucine mutants. Simulations were carried out with and without the 
bridging water (number 1H in the X-ray structure) in the alanine 
mutant and without this water in the leucine case. Each structure 
was relaxed by energy minimisation using a 10 A non-bonded cutoff 
under the following protocol. Three sets of 200 cycles of template 
forcing to the initial coordinates with restraints of 50, 20 and 5 
kcal/A, respectively, then unconstrained minimisation until the aver- 
age absolute derivative fell below 0.01 kcal/A. Structure manipulation 
and inspection was carried out using InsightlI 2.35 and energy calcu- 
lations with Discover 2.95 (Biosym Technologies Inc.) using the cvff 
forcefield [8]. 
2.2. Chemicals and growth media 
Agarose, low-melting-point agarose, ethidium-bromide and sodium 
pyruvate were from Sigma. NADH disodium salt was from Boehrin- 
ger Corp. Other reagents were from BDH. The Escherichia coli strains 
were cultured in double strength (2x) YT broth (1% yeast extract, 
1.6% tryptone, 0.5% NaC1) or grown on 2×YT agar plates. For 
competent cells the TG2 strain of E. coli was grown on minimal plate 
(containing 0.6% Na2HPO4, 0.3% KH2PO4, 0.1% NH4C1, 0.05% 
NaC1 and 1.5% agar). 
2.3. Genetic manipulation procedures 
Restriction endonucleases and DNA ligases were purchased from 
Boehringer Corp. and used according to the manufacturer's instruc- 
tions. Isolation of plasmid DNA, preparation of DNA fragments, 
ligation and transformation f E. coli cells were carried out according 
to Sambrook et al. [9]. 
The oligonucleotide site-directed mutagenesis was generated by the 
PCR-based overlap extension method [10] using a Perkin Elmer DNA 
thermal cycler. The template used for the mutagenesis was 
pHLDHA22 [11] containing human LDH-A (muscle) eDNA purified 
from E. coil TG2 cells that were used as a host for transformation a d 
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expression of human LDH genes in plasmids pKK223-3 and pUC-18 
(Pharmacia P.L.). 
Oligonucleotides 5'-GTGITTAITTG/GAC/TGGIGTTIGCA/ATC- 
3' and 5'-CTGITTA/TTGIGAG/CTGIGTT/GCAIATC-3' were used 
for the site-directed mutagenesis of the eDNA coding for the human 
LDH-A gene to give proteins S163L and S163A, respectively (nucleo- 
tides in bold type show the mutant regions). These were synthesized 
using a Perseptive Biosystems Expedite DNA synthesizer. 
The conditions of the mutagenesis u ed to generate the two over- 
lapping fragments were identical (20 ng of template DNA, 40 ng of 
each primer and unit DNA polymerase in 50 /al total volume) and 
were tested using Taq polymerase. The final mutagenesis was carried 
out using Pfu polymerase which has proof reading activity. In the first 
stage N- and C-terminal fragments were obtained using the following 
parameters: 94°C for 1 min, 50°C for 1.5 min, 72°C for 2 min for 20 
cycles. The PCR products were run on a 0.8% low-melting-point 
(LMP) agarose gel, the ~ 1.7 kb bands were cut out and purified 
using phenol extraction. Each purified fragment was added to a sub- 
sequent PCR reaction where they were overlapped and extended, then 
amplified during the third reaction. The conditions for the second 
reaction were: 94°C for 2 min, 50°C for 1 min, 72°C for 2 min for 
7 cycles and for the third: 94°C for 1.5 min, 50°C for 1 rain, 72°C for 
3 rain for 20 cycles. 
2.4. Nucleotide sequencing 
Nucleotide sequence determinations were made by the chain termi- 
nation method of Sanger et al. [12] using the Sequenase version 2.0 
DNA sequencing Kit from USB and autoradiography detection (S aS- 
labelled dATP used was from Amersham International plc., Cleve- 
land, OH). 
2.5. Purification of wild-type and mutant hLDH proteins from E. coli 
Cells grown in 2 × YT broth (containing Ampicillin) were harvested 
by centrifugation (4000xg, 20 min) and were resuspended in mini- 
mum volume of 50 mM TEA (triethanolamine hydrochloride) atpH 6 
then lysed by sonication on ice (5× 15 s at power level 7 using a 
Model XL 2010 sonicator from Heat Systems Ultrasonics, Farming- 
dale, NY). After the cell debris was removed by centrifugation 
(15000xg, 30 min) the enzymes were precipitated by adding 40 g 
(NH4)2SOJ100 ml of the supernatant and left for 1 h on ice. The 
enzymes were recovered by centrifugation (15000xg, 20 rain). The 
pellet was dissolved in a minimum volume of 50 mM TEA buffer (pH 
6) and dialysed against 50 vol. of that buffer overnight at 4°C. The 
dehydrogenases were purified by affinity chromatography on a 3 x 12 
cm column of oxamate-Sepharose pre-washed with 0.5 mM NADH. 
The enzymes were added to the column in 10 mM NADH and eluted 
with 50 mM TEA at pH 9 containing 1 M NaC1 then stored as the 
precipitate formed when 40 g (NH4)2SO4/100 ml of eluate was added. 
The S163L mutant gave much better chromatographic separation 
when the column was pre-washed with 10 mM NADH in 10 mM 
TEA buffer at pH 6. Enzyme content of the eluates was estimated 
from the intensity of Coomassie Blue stains after electrophoresis on
polyacrylamide g l. 
2.6. Steady-state kinetics 
The enzyme precipitates from the purification were pelleted by cen- 
trifugation (15 000 × g, 20 rain) then resuspended in minimum volume 
of 20 mM bis-Tris-50 mM KC1 buffer (pH 6) and dialysed against 100 
vol. of this buffer overnight at 4°C. Protein concentrations of the 
purified enzymes were determined measuring the absorbance at 280 
nm using absorbance values of 1.20 for 1.0 mg/ml LDH-M4. These 
values were calculated from the gene-derived contents of tryptophan 
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and tyrosine of the protein subunits. The steady-state kinetic measure- 
ments were made by following the change in absorbance at 340 nm 
(366 nm at higher pyruvate (> 30 raM) concentrations) during the 
NADH to NAD + conversion at 25°C. The initial concentration of
NADH was 200 laM and reaction was initiated by addition of pyr- 
uvate. The values of Km for NAD + were measured in steady-state 
initial velocity experiments at pH 9 (50 mM glycine) and 0.2 mM L- 
lactate. Kinetic constants were evaluated using Grafit version 3 
(Erithacus Software, Staines, UK) using V=Vm~x[S]/([S]+KM+[S]Z/Ki). 
2. Z Measurements of enzyme activity in rapM mixing experiments 
Measurements of the steady-state rate over a time period of 0.2 s 
(too short to allow build up of the abortive ternary complex) were 
made using an SF 51 stopped-flow apparatus (Hi-Tech, Salisbury, 
Wiltshire, UK). One volume of enzyme solution was mixed with 
one volume of an NADH/pyruvate mixture and the decrease in ab- 
sorbance was recorded as the NADH was oxidized to NAD +. After 
mixing, the enzyme concentration was 0.3 mg/ml and NADH 0.2 raM. 
Experiments were performed with pyruvate concentrations of 0.05 
mM, 0.1 mM, 0.2 mM and 0.4 raM. The buffer contained 20 mM 
bis-Tris/50 mM KCI, pH 6. 
2.8. Measuring binding constants by tryptophan quenching 
The dissociation constants of NADH and NAD + were measured 
from the decrease in fluorescence of enzyme tryptophan on complex 
formation. Excitation was at 285 nm and emission at 340 nm using a 
Perkin Elmer spectrofluorimeter. For each experiment 2.0 ml of a 
freshly made 2 gM solution of the LDH apoenzyme was used. The 
concentrations of ligand stock solutions were 1 mM NADH and 0.5 
M NAD +. Each stock solution was added in 2 I11 aliquots during the 
titrations. For the NADH titrations the binding curves were fitted to 
a tight ligand binding equation and corrected for the inner filter effect 
of NADH: 
signal -- 
SX- (K  + E + L-X~(((K + E + L)2-4*E*L)/2*E)*(SX-SN) 
where SX is the initial fluorescence intensity, SN the final intensity, K
is the dissociation constant, E the concentration f enzyme active sites 
and L the concentration f nucleotide. For the NAD + titrations the 
binding curves were similarly corrected for the inner filter effect and 
fitted to the weak ligand binding equation: 
signal = SX- (L* (SX-SN) / (K  + L)) 
In a similar fashion, the dissociation constants of oxamate from the 
E:NADH complexes were measured from the decrease of the fluo- 
rescence of bound NADH. Excitation was at 340 nm and emission 
measured at 435 nm. For each experiment 2.0 ml of a freshly made 
solution of an equimolar mixture of NADH and LDH. The concen- 
tration of protein used was 15 I.tM in the case of S163L and 2 gM in 
the case of S 163A and wild type. Titrations were performed by adding 
2 lal aliquots of 0.8 M oxamate to the S163L:NADH solution, and 2 gl 
aliquots of 10 mM oxamate to the SI63A:NADH and WT:NADH 
solutions. Ka values were obtained by fitting the experimental titration 
curves to the weak ligand binding equation described above. 
3. Results and discussion 
3.1. Mutagenesis 
Two primers, each 24 nucleotides long, were designed to 
Table 1 
Kinetic and binding constants for the wild-type and mutant proteins 
Protein kcat KM pyr Ki Kd oxamate Ka NADH Kd NAD ÷ KM NAD +~ 
(s- l ) (mM) (mM) (IxM) (gM) (/aM) 
(BM) 
Wild type 260+ 3 0.158+0.006 3.9+0.7 26_+ 3 0.62_+0.05 198_+ 16 102_+ 10 
S163A 168_+13 0.249_+0.049 4.7_+0.9 49_+ 5 0.94_+0.06 172_+ 7 324_+ 7 
S163L 119_+ 3 6.5 _+1.0 none 3100_+100 5.6 _+0.6 230_+15 347_+ 7 
Conditions are described in Section 2. 
~Apparent KM at 0.2 mM lactate, pH 9. 











20 40 60 80 I00 120 
[pyruvate] (mM) 
1: g. 1. Steady-state kinetic behaviour of wild-type, S163A and 
S 63L mutants of human LDH-M4 obtained by monitoring the de- 
crease in absorbance at 340 nm. Catalytic rate constants are given 
il moles ubstrate consumed per mole active site per second. The 
c ,lculated kinetic constants corresponding to the fitted curves are in 
yen in Table 1. 
ater the eDNA coding for the A isoform of the human LDH 
g~:ne to replace serine-163 in the M4 protein by alanine or by 
kucine. Site-directed mutagenesis u ing the pHLDHA22 plas- 
r~id was carried out, the products ligated into pKK223-3 and 
t:ansformed into TG2 host cells as described in Section 2. The 
lvo mutant genes were each sequenced in the region coding 
t )r amino acid 163 and showed only the required changes to 
tae published sequence [13]. The transformed bacteria all 
s rongly over produced their respective LDH proteins. The 
I'urified enzymes were all greater than 95% pure as judged 
l y polyacrylamide g l electrophoresis in SDS. 
." 2. Kinetics and binding experiments 
The steady-state kinetic data of the wild-type and alanine 
~ mtant shown in Fig. 1 can, in principle, be fitted to give the 
11ree kinetic constants k~.~t, KM (pyruvate) and Ki. In practice 
laese constants are so strongly coupled it is difficult to obtain 
reliable fit. For this reason, stopped-flow kinetic measure- 
] lents were carried out to determine kcat and KM (pyruvate) 
t ,efore the onset of substrate inhibition. The 
]',:NAD+:pyruvate complex is a slowly formed species and 
~equires 1 2 s to accumulate detectably in these conditions 
~see Fig. 2). These data were used, in turn, to fit the steady- 
tate kinetic curves and so determine r liable Ki values. Fitting 
1 he data of the leucine mutant o these three constants gave a 
,~:'i value greater than 1 M, i.e. substrate inhibition is unde- 
~ectable in this protein. Binding affinities for the proteins with 
NADH and NAD ~ were determined by titration of protein 
~tuorescence emission. Binding affinities for the binary com- 
i,lexes of the proteins and NADH with oxamate were deter- 
ained by titration on the NADH fluorescense emission. All 
hese results are shown in Table 1. 
'.3. Suppression of  substrate inhibition 
In the absence of crystal structures molecular modelling can 
~rovide valuable insights into possible structural and energetic 
onsequences of point mutations in proteins. Superimpostion 
~f the Ca positions of the four minimised ternary complexes 
n the six possible permutations resulted in RMS deviations of 
~he Ca positions lying between 0.30 and 0.45 ,~. These low 
.... alues imply that the two mutations have little effect on the 
overall structures of the proteins. Fig. 3 shows the corre- 
sponding structures around position 163. All the complexes 
exhibit catalytically competent geometry with the A-side hy- 
dride of NADH in close contact with the carbonyl carbon of 
pyruvate. Modelling the S163A complex with and without an 
intervening water molecule gives geometries closely similar to 
wild type. For example, the nicotinamide amide carbon to 163 
Cct distance for S163A with an intervening water (Fi B. 3b) is 
0.2 A longer than that in wild type (Fig. 3a), and 0.2 A short- 
er when modelled without he water (Fig. 3c). Despite the loss 
of hydrogen bonding between NADH and residue 163, the K,l 
for NADH of the S163A mutant is only 1.5 times higher than 
that of the wild type and NADH. This may be due to a trade 
off in the wild-type complex between favourable nthalpy 
from hydrogen bonding and unfavourable ntropy caused 
by sequestering a water molecule from the solvent. This, in 
turn, implies that the model of S163A without an intervening 
water (Fig. 3c) is correct and that the principle role of serine- 
163 in LDHs is to position the nicotinamide ring for reaction, 
rather than to contribute towards the total NADH binding 
energy. Similar behaviour is shown by the S163A mutant of a 
bacterial protein [15]. A greater change in geometry occurred 
in the S163L complex due to the larger bulk of this hydro- 
phobic residue. In this case, the nicotinamide amide carbon to 
163 Ca distance is predicted to be 0.5 A longer than in wild 
type. The nicotinarnide amide has also rotated out of the 
plane of the ring by 60 °. This disruption is reflected in a Kd 
value for the interaction between S163L and NADH (Table 1) 
which is 10-fold higher than wild type. This corresponds to a 
loss of about half the contribution usually made by the dihy- 
dronicotinamide group towards NADH binding in LDHs 
[14]. 
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Fig. 2. Determination f steady-state kinetic parameters by stopped 
flow rapid-mixing methods for wild-type and S163A proteins. The 
formation of the inhibitory NAD+/pyruvate adduct is slow and 
does not occur to any measurable extent during the first 100 ms of 
the enzyme catalysed reaction. The rates are the initial velocities giv- 
en in moles substrate consumed per mole active site per second 
measured over the first 50 ms of reaction. 
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./~ SER 163 :, 
p-52 
(a) ,,..%, pyruvate 
7 ALA 163 ., 
. . . .  
(b) pyruvate 
(C) ~ pyruvate (d) 
pyruvate 
Fig. 3. Geometries around residue 163 in the energy minimised ternary complexes. ©, Carbon and hydrogen atoms; O, nitrogen and oxygen. 
Hydrogen bonds are shown as light dashed lines and distances in italics. Other distances are in bold dashed lines and bold text. (a) Wild type; 
(b) S163A with intervening water; (c) S163A without intervening water; (d) S163L. 
values for all three proteins are very similar, all lying around 
200 pM. This observation is consistent with previous work 
which showed that the oxidised nicotinamide group contrib- 
utes nothing towards the overall binding of NAD + to 
LDHs, in fact the binding of NAD + is weaker than adeno- 
sine-diphosphate-ribose. In the light of these observations the 
complete loss of substrate inhibition in S163L might, at first 
sight, be surprising. However, inspection of Table 1 indicates 
that the reason that substrate inhibition has been lost is a 
consequence of the much weaker binding of pyruvate in this 
mutant. This weakening of pyruvate binding is inferred from 
the 40-fold increase in KM for pyruvate by S163L and also by 
the 120-fold increase in Kd for oxamate by S163L:NADH 
compared with the wild type:NADH. Hence it must be weak- 
ening of pyruvate binding rather than weakening of NAD + 
binding which results in no significant formation of the inhib- 
itory adduct between pyruvate and S163L:NAD + under the 
reaction conditions tudied. 
3.4. Mechanistic interpretation 
The striking feature of the S163L mutation is that although 
the residue makes contact with the nicotinamide group its 
most potent effect is on substrate affinity rather than coen- 
zyme binding or catalytic rate. The simplest explanation re- 
quires the postulation of two forms of binary complex 
between NADH or NAD + and enzyme and also a con- 
sideration of the nature of an obligatory order reaction. 
The fact that LDH must bind the coenzyme first demonstrates 
that the substrate binding site is only formed after establishing 
a receptive binary complex. The 'receptive' binary complex (r) 
is postulated to have geometry similar to that seen in crystal 
structures and can bind pyruvate tightly in the normal man- 
ner. The 'unreceptive' forms (u) have a deformed geometry 
and cannot bind pyruvate as shown in the scheme below: 
E:NADH(r) ,~ '~ E:NADH(r):Pymwtte - = E:NAD+(r):Lactate-~ ~ E:NAD+(r) 
1L 1L 
E:NADI-I(u) E:NAD +(u) 
This deformed geometry is most likely characterised by 
perturbations of the nicotinamide ring from its orientation 
in the wild-type complexes, due to blocking of the nicotinami- 
de amide pocket by the inserted leucine-163. The identifica- 
tion by NMR of a mixture of LDH/NAD + binary complexes 
of this kind has been reported [16]. Although the equilibrium 
between E:NADH(r) and E:NADH(u) in the mutant is heav- 
ily in favour of the latter, the binding of pyruvate can induce 
the receptive state at the cost of net binding energy. Under 
these conditions the observed KM for pyruvate will approxi- 
mate to the product of the KM of E:NADH(r) and its frac- 
tional population, but the observed kcat will just reflect the 
effectiveness of the ternary complex to proceed to products. 
This model accounts for the behaviour of both mutant pro- 
teins in the following way. Suppose that both wild type and 
S163A bind NADH almost exclusively in the receptive geom- 
etry. Then the 1.5-fold weaker binding of NADH shown by 
S163A is echoed in a 1.6-fold raising of the KM for pyruvate, a
1.6-fold lowering of kc~t and a 1.2-fold raising of Ki. Suppose 
that only about 1% of the binary complex of S163L and 
NADH is in the receptive form and the rest is unreceptive. 
The fact that there is only a 10-fold increase in Ka for NADH 
relative to wild type suggests that the dihydronicotinamide 
group in the unreceptive form still contributes to NADH 
binding as this group usually contributes by a factor between 
( M. Eszes et al./FEBS Letters 399 (1996) 193-197 197 
III z and 103 [14]. The receptive form can bind pyruvate and 
the enzyme reaction proceeds with a 2-fold reduction in kcat 
due to a slightly poorer geometry of the catalytic complex 
than that of wild type. However, the fact that only 1% of 
the binary complex is in the receptive form results in a 100- 
fi)ld increase in the observed K~.I of S163L for pyruvate. If the 
g~ometric requirements for forming the abortive 
I :NAD + :pyruvate complex are similar to those for formation 
( f E:NADH(p):pyruvate hen a similar proportion of recep- 
Ive and unreceptive complexes of S163L with NAD + would 
l use Ki to at least 0.4 M. 
~t. Conclusions 
The role of serine-163 in lactate dehydrogenases appears to 
1,e one of positioning the nicotinamide group of the cofactor 
1 ather than contributing significantly towards binding. Hence, 
i l  the human protein replacing serine-163 by alanine has a 
~rnall effect upon the kinetic properties of the enzyme with 
I espect o wild type, Replacement of serine-163 with the larger 
]zucine residue, however, has a pronounced effect upon the 
I inetic properties of the protein, while the k~,~, of this mutant 
~g reduced by only 50%, substrate inhibition is completely 
~emoved. This effect cannot be simply explained by a weak- 
ning of NAD + binding leading to a reduction in the rate of 
;~bortive complex formation, since the Kd for NAD + in this 
nutant is similar to wild type. These effects, along with the 
0-fold increase in K,I for NADH and the 40-fold increase in 
~\~ for pyruvate are best explained by a model in which the 
finding energy of pyruvate is used to re-align the nicotin- 
tmide group of the cofactor thus increasing both K~.I and Ki 
Or this substrate while leaving k,:~ largely unaltered. 
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